Developed by the SGO Education Committee's Late Breaking Subcommittee, this is part of a collection downloadable PDFs summarizing takeaways from recent trials presented at meetings, the newest FDA approvals, etc.

This specific PDF summarizes the latest from ESMO 2024, to include PRIMA/ENGOT-OV/GOG-3012 final analysis.